Neuromuscular-blocking drugs, or Neuromuscular blocking agents, block transmission at the neuromuscular junction, causing paralysis of the affected skeletal muscles. This is accomplished via their act
Fig.3 A simple illustration of how vecuronium binds to the nicotinic receptor. Its D-ring binds to the receptor at two points and the lipophillic side of the molecule repels cations from flowing through the ion-channel